• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

等离子体活化水:一种用于灭活S蛋白以预防新型冠状病毒感染的替代消毒剂。

Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection.

作者信息

Guo Li, Yao Zhiqian, Yang Lu, Zhang Hao, Qi Yu, Gou Lu, Xi Wang, Liu Dingxin, Zhang Lei, Cheng Yilong, Wang Xiaohua, Rong Mingzhe, Chen Hailan, Kong Michael G

机构信息

State Key Laboratory of Electrical Insulation and Power Equipment, Center for Plasma Biomedicine, Xi'an Jiaotong University, Xi'an 710049, PR China.

School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, PR China.

出版信息

Chem Eng J. 2021 Oct 1;421:127742. doi: 10.1016/j.cej.2020.127742. Epub 2020 Nov 20.

DOI:10.1016/j.cej.2020.127742
PMID:33235538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7677677/
Abstract

SARS-CoV-2 is a highly contagious virus and is causing a global pandemic. SARS-CoV-2 infection depends on the recognition of and binding to the cellular receptor human angiotensin-converting enzyme 2 (hACE2) through the receptor-binding domain (RBD) of the spike protein, and disruption of this process can effectively inhibit SARS-CoV-2 invasion. Plasma-activated water efficiently inactivates bacteria and bacteriophages by causing damage to biological macromolecules, but its effect on coronavirus has not been reported. In this study, pseudoviruses with the SARS-CoV-2 S protein were used as a model, and plasma-activated water (PAW) effectively inhibited pseudovirus infection through S protein inactivation. The RBD was used to study the molecular details, and the RBD binding activity was inactivated by plasma-activated water through the RBD modification. The short-lived reactive species in the PAW, such as ONOO, played crucial roles in this inactivation. Plasma-activated water after room-temperature storage of 30 days remained capable of significantly reducing the RBD binding with hACE2. Together, our findings provide evidence of a potent disinfection strategy to combat the epidemic caused by SARS-CoV-2.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种高传染性病毒,正在引发全球大流行。SARS-CoV-2感染依赖于刺突蛋白的受体结合域(RBD)对细胞受体人血管紧张素转换酶2(hACE2)的识别和结合,而破坏这一过程可有效抑制SARS-CoV-2入侵。等离子体活化水通过对生物大分子造成损伤,可有效灭活细菌和噬菌体,但其对冠状病毒的作用尚未见报道。在本研究中,以表达SARS-CoV-2 S蛋白的假病毒为模型,等离子体活化水(PAW)通过使S蛋白失活有效抑制假病毒感染。利用RBD研究分子细节,等离子体活化水通过修饰RBD使RBD结合活性失活。PAW中的短寿命活性物质,如过氧亚硝酸盐(ONOO),在这种失活过程中起关键作用。室温储存30天的等离子体活化水仍能显著降低RBD与hACE2的结合。总之,我们的研究结果为对抗SARS-CoV-2引起的疫情提供了一种有效的消毒策略的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae3/7677677/1974821d0044/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae3/7677677/f9a1abc985eb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae3/7677677/30e1c332d25a/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae3/7677677/1974821d0044/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae3/7677677/f9a1abc985eb/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae3/7677677/30e1c332d25a/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cae3/7677677/1974821d0044/gr4_lrg.jpg

相似文献

1
Plasma-activated water: An alternative disinfectant for S protein inactivation to prevent SARS-CoV-2 infection.等离子体活化水:一种用于灭活S蛋白以预防新型冠状病毒感染的替代消毒剂。
Chem Eng J. 2021 Oct 1;421:127742. doi: 10.1016/j.cej.2020.127742. Epub 2020 Nov 20.
2
1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection.1,2,3,4,6-五没食子酰葡萄糖,一种RBD-ACE2结合抑制剂,用于预防新型冠状病毒感染。
Front Pharmacol. 2021 Mar 4;12:634176. doi: 10.3389/fphar.2021.634176. eCollection 2021.
3
Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.用于阻断新冠病毒刺突蛋白受体结合域的潜在嵌合肽。
F1000Res. 2020 Jun 9;9:576. doi: 10.12688/f1000research.24074.1. eCollection 2020.
4
Efficient disinfection of SARS-CoV-2-like coronavirus, pseudotyped SARS-CoV-2 and other coronaviruses using cold plasma induces spike protein damage.利用冷等离子体高效消毒 SARS-CoV-2 样冠状病毒、假型 SARS-CoV-2 及其他冠状病毒可诱导刺突蛋白损伤。
J Hazard Mater. 2022 May 15;430:128414. doi: 10.1016/j.jhazmat.2022.128414. Epub 2022 Feb 4.
5
Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.源自马蹄蝠 ACE2 直系同源物的突变增强了 ACE2-Fc 对 SARS-CoV-2 的中和作用。
PLoS Pathog. 2021 Apr 9;17(4):e1009501. doi: 10.1371/journal.ppat.1009501. eCollection 2021 Apr.
6
Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach.评估 SARS-CoV-2 刺突 RBD 和 hACE2 的分子相互作用、物理化学参数和保守模式:计算和分子动力学方法。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1708-1723. doi: 10.26355/eurrev_202102_24881.
7
Inactivation mechanism of cold plasma combined with 222 nm ultraviolet for spike protein and its application in disinfecting of SARS-CoV-2.冷等离子体与 222nm 紫外线联合灭活刺突蛋白的机制及其在 SARS-CoV-2 消毒中的应用。
J Hazard Mater. 2024 Mar 5;465:133458. doi: 10.1016/j.jhazmat.2024.133458. Epub 2024 Jan 9.
8
Contact residue contributions to interaction energies between SARS-CoV-1 spike proteins and human ACE2 receptors.接触残基对 SARS-CoV-1 刺突蛋白与人 ACE2 受体相互作用能的贡献。
Sci Rep. 2021 Jan 13;11(1):1156. doi: 10.1038/s41598-020-80942-6.
9
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.一种针对严重急性呼吸综合征冠状病毒 2 刺突蛋白 RBD 的疫苗可诱导保护性免疫。
Nature. 2020 Oct;586(7830):572-577. doi: 10.1038/s41586-020-2599-8. Epub 2020 Jul 29.
10
Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的抑制剂筛选及其阻断病毒进入机制的能力:一项病毒信息学研究。
Saudi J Biol Sci. 2021 Jun;28(6):3262-3269. doi: 10.1016/j.sjbs.2021.02.066. Epub 2021 Feb 26.

引用本文的文献

1
A portable electrochemical device with UiO-66@polydopamine modified screen-printed electrodes for rapid detection of manganese ions.一种具有UiO-66@聚多巴胺修饰丝网印刷电极的便携式电化学装置,用于快速检测锰离子。
Mikrochim Acta. 2025 Aug 21;192(9):612. doi: 10.1007/s00604-025-07459-5.
2
A Cold Plasma Technology for Ensuring the Microbiological Safety and Quality of Foods.一种确保食品微生物安全与质量的冷等离子体技术。
Food Eng Rev. 2022;14(4):535-554. doi: 10.1007/s12393-022-09316-0. Epub 2022 Jun 24.
3
Viral inactivation of murine coronavirus via multiple gas plasma-derived reactive species.

本文引用的文献

1
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.基于携带 SARS-CoV-2 S 蛋白的水疱性口炎病毒(VSV)假病毒和过表达 ACE2 的 BHK21 细胞的稳健中和测定法。
Emerg Microbes Infect. 2020 Dec;9(1):2105-2113. doi: 10.1080/22221751.2020.1815589.
2
The hallmarks of COVID-19 disease.新型冠状病毒疾病的特征。
PLoS Pathog. 2020 May 22;16(5):e1008536. doi: 10.1371/journal.ppat.1008536. eCollection 2020 May.
3
Medical Gas Plasma Jet Technology Targets Murine Melanoma in an Immunogenic Fashion.
通过多种气体等离子体衍生的活性物质对鼠冠状病毒进行病毒灭活
Redox Biol. 2025 May;82:103591. doi: 10.1016/j.redox.2025.103591. Epub 2025 Mar 10.
4
Graphdiyne biomaterials: from characterization to properties and applications.石墨炔生物材料:从表征到性质及应用
J Nanobiotechnology. 2025 Mar 4;23(1):169. doi: 10.1186/s12951-025-03227-y.
5
Improving the use of CRISPR/Cas9 gene editing machinery as a cancer therapeutic tool with the help of nanomedicine.借助纳米医学提高CRISPR/Cas9基因编辑机制作为癌症治疗工具的应用效果。
3 Biotech. 2025 Jan;15(1):17. doi: 10.1007/s13205-024-04186-1. Epub 2024 Dec 19.
6
Inactivation of Pseudovirus Expressing the D614G Spike Protein Mutation using Nitric Oxide-Plasma Activated Water.使用一氧化氮-等离子体活化水灭活表达D614G刺突蛋白突变的假病毒
Adv Sci (Weinh). 2024 Dec;11(48):e2411515. doi: 10.1002/advs.202411515. Epub 2024 Nov 13.
7
Plasma activated water pre-treatment substantially enhances phage activity against biofilms.等离子体活化水预处理可显著增强噬菌体对生物膜的活性。
Biofilm. 2024 Oct 18;8:100230. doi: 10.1016/j.bioflm.2024.100230. eCollection 2024 Dec.
8
Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial.经等离子体激活水雾化吸入治疗抗病毒治疗失败的进展性中度 COVID-19 患者:一项随机对照初步试验。
BMC Infect Dis. 2024 Sep 12;24(1):960. doi: 10.1186/s12879-024-09886-w.
9
Plasma-activated water: Candidate hand disinfectant for SARS-CoV-2 transmission disruption.等离子体活化水:用于破坏SARS-CoV-2传播的候选手部消毒剂。
Heliyon. 2024 Jul 9;10(15):e34337. doi: 10.1016/j.heliyon.2024.e34337. eCollection 2024 Aug 15.
10
Nanomaterials in Medicine: Understanding Cellular Uptake, Localization, and Retention for Enhanced Disease Diagnosis and Therapy.医学中的纳米材料:理解细胞摄取、定位和滞留以增强疾病诊断与治疗
Aging Dis. 2024 Feb 22;16(1):168-208. doi: 10.14336/AD.2024.0206-1.
医用气体等离子体射流技术以免疫原性方式靶向小鼠黑色素瘤。
Adv Sci (Weinh). 2020 Mar 30;7(10):1903438. doi: 10.1002/advs.201903438. eCollection 2020 May.
4
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2.利用人血管紧张素转化酶 2 进入 SARS-CoV-2 的结构和功能基础
Cell. 2020 May 14;181(4):894-904.e9. doi: 10.1016/j.cell.2020.03.045. Epub 2020 Apr 9.
5
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.针对 SARS-CoV-2 和其他人类冠状病毒的中和抗体。
Trends Immunol. 2020 May;41(5):355-359. doi: 10.1016/j.it.2020.03.007. Epub 2020 Apr 2.
6
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV.SARS-CoV-2 和 SARS 冠状病毒受体结合域中高度保守的隐蔽表位。
Science. 2020 May 8;368(6491):630-633. doi: 10.1126/science.abb7269. Epub 2020 Apr 3.
7
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.SARS-CoV-2 刺突受体结合域与 ACE2 受体复合物的结构。
Nature. 2020 May;581(7807):215-220. doi: 10.1038/s41586-020-2180-5. Epub 2020 Mar 30.
8
Structural basis of receptor recognition by SARS-CoV-2.SARS-CoV-2 受体识别的结构基础。
Nature. 2020 May;581(7807):221-224. doi: 10.1038/s41586-020-2179-y. Epub 2020 Mar 30.
9
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.SARS-CoV-2 刺突糖蛋白的特征及其对病毒进入的影响,以及与 SARS-CoV 的免疫交叉反应性。
Nat Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9.
10
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2.从基因组角度看 SARS-CoV-2 的起源与出现。
Cell. 2020 Apr 16;181(2):223-227. doi: 10.1016/j.cell.2020.03.035. Epub 2020 Mar 26.